Baxter Operating Margin 2010-2024 | BAX

Current and historical operating margin for Baxter (BAX) over the last 10 years. The current operating profit margin for Baxter as of December 31, 2024 is 10.32%.
Baxter Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2024-12-31 $10.64B $0.01B 0.13%
2024-09-30 $10.64B $0.57B 5.32%
2024-06-30 $10.54B $0.59B 5.60%
2024-03-31 $10.44B $0.77B 7.33%
2023-12-31 $10.36B $0.71B 6.82%
2023-09-30 $8.97B $-0.10B -1.13%
2023-06-30 $9.98B $-3.16B -31.68%
2023-03-31 $9.86B $-2.88B -29.19%
2022-12-31 $10.06B $-2.85B -28.29%
2022-09-30 $13.79B $-2.43B -17.63%
2022-06-30 $13.40B $0.96B 7.18%
2022-03-31 $12.91B $1.12B 8.70%
2021-12-31 $12.15B $1.35B 11.11%
2021-09-30 $12.45B $1.73B 13.92%
2021-06-30 $12.20B $1.69B 13.86%
2021-03-31 $11.82B $1.60B 13.51%
2020-12-31 $11.67B $1.62B 13.84%
2020-09-30 $11.53B $1.75B 15.14%
2020-06-30 $11.41B $1.78B 15.59%
2020-03-31 $11.53B $1.80B 15.60%
2019-12-31 $11.36B $1.77B 15.60%
2019-09-30 $11.14B $1.62B 14.56%
2019-06-30 $11.05B $1.50B 13.58%
2019-03-31 $11.06B $1.54B 13.88%
2018-12-31 $11.10B $1.58B 14.27%
2018-09-30 $11.08B $1.49B 13.42%
2018-06-30 $11.02B $1.40B 12.74%
2018-03-31 $10.79B $1.37B 12.67%
2017-12-31 $10.58B $1.29B 12.17%
2017-09-30 $10.43B $1.30B 12.49%
2017-06-30 $10.28B $1.19B 11.56%
2017-03-31 $10.26B $0.91B 8.87%
2016-12-31 $10.16B $0.75B 7.33%
2016-09-30 $10.12B $0.62B 6.13%
2016-06-30 $10.05B $0.53B 5.23%
2016-03-31 $9.94B $0.55B 5.48%
2015-12-31 $9.97B $0.45B 4.50%
2015-09-30 $10.15B $0.46B 4.55%
2015-06-30 $10.38B $0.59B 5.66%
2015-03-31 $12.06B $1.16B 9.61%
2014-12-31 $13.50B $1.74B 12.88%
2014-09-30 $15.03B $2.09B 13.93%
2014-06-30 $16.03B $2.53B 15.79%
2014-03-31 $15.55B $2.70B 17.36%
2013-12-31 $15.15B $2.74B 18.11%
2013-09-30 $14.33B $2.72B 18.99%
2013-06-30 $14.09B $2.84B 20.17%
2013-03-31 $14.00B $2.79B 19.95%
2012-12-31 $13.94B $2.77B 19.88%
2012-09-30 $14.03B $2.87B 20.47%
2012-06-30 $14.03B $2.84B 20.24%
2012-03-31 $14.00B $2.89B 20.68%
2011-12-31 $13.89B $2.95B 21.20%
2011-09-30 $13.80B $2.84B 20.61%
2011-06-30 $13.54B $2.88B 21.27%
2011-03-31 $13.20B $2.75B 20.82%
2010-12-31 $12.84B $2.14B 16.63%
2010-09-30 $12.82B $2.35B 18.31%
2010-06-30 $12.74B $2.30B 18.03%
2010-03-31 $12.67B $2.35B 18.52%
2009-12-31 $12.56B $2.88B 22.90%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $14.818B $10.636B
Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $227.162B 27.40
Boston Scientific (BSX) United States $140.689B 37.90
Stryker (SYK) United States $132.255B 28.42
EssilorLuxottica (ESLOY) France $128.431B 0.00
Medtronic (MDT) Ireland $105.938B 15.47
Lonza Group Ag (LZAGY) Switzerland $47.424B 0.00
Haleon (HLN) United Kingdom $46.151B 26.20
ResMed (RMD) United States $31.269B 24.08
Agilent Technologies (A) United States $29.217B 19.30
GE HealthCare Technologies (GEHC) United States $28.556B 13.89
Terumo (TRUMY) Japan $28.160B 0.00
Koninklijke Philips (PHG) Netherlands $22.192B 15.85
Zimmer Biomet Holdings (ZBH) United States $19.373B 12.24
Insulet (PODD) United States $17.332B 74.11
Smith & Nephew SNATS (SNN) United Kingdom $11.356B 0.00
Sunny Optical Technology (SNPTF) China $7.609B 0.00
Lantheus Holdings (LNTH) United States $6.938B 17.06
Bio-Rad Laboratories (BIO) United States $6.672B 23.10
Demant (WILYY) Denmark $6.644B 0.00
Prestige Consumer Healthcare (PBH) United States $3.977B 18.98
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Perrigo (PRGO) Ireland $3.455B 9.89
ICU Medical (ICUI) United States $3.400B 29.07
Haemonetics (HAE) United States $2.872B 13.52
Envista Holdings (NVST) United States $2.614B 20.80
GN Store Nord (GNNDY) Denmark $2.188B 14.75
LeMaitre Vascular (LMAT) United States $1.946B 44.47
QuidelOrtho (QDEL) United States $1.698B 14.22
AtriCure (ATRC) United States $1.565B 0.00
Kestra Medical Technologies (KMTS) United States $1.214B 0.00
Green Thumb Industries (GTBIF) United States $1.189B 18.67
AdaptHealth (AHCO) United States $1.051B 10.12
BioLife Solutions (BLFS) United States $1.041B 0.00
InMode (INMD) Israel $1.038B 8.67
Neogen (NEOG) United States $0.953B 12.19
Phibro Animal Health (PAHC) United States $0.700B 10.74
Evolus (EOLS) United States $0.686B 0.00
Curaleaf Holdings (CURLF) Canada $0.649B 0.00
Valneva SE (VALN) France $0.552B 0.00
Owens & Minor (OMI) United States $0.535B 4.56
CeriBell (CBLL) United States $0.532B 0.00
Capricor Therapeutics (CAPR) United States $0.514B 0.00
Tilray Brands (TLRY) Canada $0.453B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.450B 0.00
Surmodics (SRDX) United States $0.394B 0.00
Omeros (OMER) United States $0.394B 0.00
SNDL (SNDL) Canada $0.368B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.329B 0.00
Cresco Labs (CRLBF) United States $0.328B 0.00
VAREX IMAGING (VREX) United States $0.302B 13.07
Viemed Healthcare (VMD) United States $0.262B 23.68
Sanara MedTech (SMTI) United States $0.262B 0.00
ZimVie (ZIMV) United States $0.261B 15.65
Sanuwave Health (SNWV) United States $0.256B 0.00
Verano Holdings (VRNOF) United States $0.251B 0.00
Aurora Cannabis (ACB) Canada $0.250B 44.40
Cerus (CERS) United States $0.242B 0.00
OraSure Technologies (OSUR) United States $0.224B 0.00
Quanterix (QTRX) United States $0.200B 0.00
Canopy Growth (CGC) Canada $0.189B 0.00
High Tide (HITI) Canada $0.187B 0.00
Biote (BTMD) United States $0.181B 4.12
TriSalus Life Sciences (TLSI) United States $0.175B 0.00
Utah Medical Products (UTMD) United States $0.172B 13.24
Brainsway (BWAY) Israel $0.155B 48.47
Jin Medical (ZJYL) China $0.147B 0.00
Organigram Global (OGI) Canada $0.135B 0.00
FitLife Brands (FTLF) United States $0.123B 15.42
Agape ATP (ATPC) $0.094B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.088B 0.00
Quipt Home Medical (QIPT) United States $0.086B 0.00
TerrAscend (TSNDF) Canada $0.083B 0.00
Exagen (XGN) United States $0.080B 0.00
MacroGenics (MGNX) United States $0.079B 0.00
Veru (VERU) United States $0.078B 0.00
Fonar (FONR) United States $0.076B 10.65
Zynex (ZYXI) United States $0.066B 24.22
United Health Products (UEEC) United States $0.065B 0.00
Cytosorbents (CTSO) United States $0.064B 0.00
Jushi Holdings (JUSHF) United States $0.063B 0.00
InterCure (INCR) Israel $0.063B 0.00
ImmuCell (ICCC) United States $0.049B 0.00
United-Guardian (UG) United States $0.038B 11.61
Apyx Medical (APYX) United States $0.037B 0.00
Modular Medical (MODD) United States $0.036B 0.00
Rockwell Medical (RMTI) United States $0.035B 51.50
Safety Shot (SHOT) United States $0.033B 0.00
Nephros (NEPH) United States $0.021B 0.00
INLIF (INLF) $0.018B 0.00
Cellectar Biosciences (CLRB) United States $0.014B 0.00
Allurion Technologies (ALUR) United States $0.011B 0.00
Flora Growth (FLGC) United States $0.010B 0.00
Trinity Biotech (TRIB) Ireland $0.010B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Meihua Medical Technologies (MHUA) China $0.008B 0.00
Innovative Eyewear (LUCY) United States $0.004B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
IM Cannabis (IMCC) Canada $0.003B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
Sharps Technology (STSS) United States $0.001B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00